KATIE ROEDL: Open Payments
NPI 1457743338 · NEOGA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 22 payments from 12 companies in 2025. Trend: 2023 $42 · 2024 $206 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $123 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Amgen Inc. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| PFIZER INC. | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
Products named: Ozempic, Wegovy, OTEZLA, JARDIANCE, TRELEGY ELLIPTA, Cologuard Collection Kit, ELIQUIS, YUPELRI.
Industry payments across IL — which companies pay providers there.
